Nautilus Biotechnology, Inc. financial data

Symbol
NAUT on Nasdaq
Location
2701 Eastlake Ave East, Seattle, WA
Fiscal year end
December 31
Former names
ARYA Sciences Acquisition Corp III (to 6/8/2021)
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.9K % -15.9%
Debt-to-equity 15.7 % +17%
Return On Equity -28.9 % -42.3%
Return On Assets -24.9 % -39.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126M shares +0.5%
Common Stock, Shares, Outstanding 126M shares +0.5%
Common Stock, Value, Issued 13K USD +8.33%
Weighted Average Number of Shares Outstanding, Basic 125M shares +0.42%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +0.42%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 50.1M USD +13%
General and Administrative Expense 31.4M USD +11.7%
Nonoperating Income (Expense) 11.3M USD -8.94%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -70.2M USD -16.9%
Earnings Per Share, Basic -0.55 USD/shares -14.6%
Earnings Per Share, Diluted -0.55 USD/shares -14.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.41M USD -94.1%
Cash, Cash Equivalents, and Short-term Investments 141M USD -23.3%
Assets, Current 144M USD -22.8%
Property, Plant and Equipment, Net 4.32M USD +0.96%
Operating Lease, Right-of-Use Asset 29.4M USD -12.7%
Other Assets, Noncurrent 1.18M USD +1.99%
Assets 260M USD -18.4%
Accounts Payable, Current 1.49M USD +30.2%
Employee-related Liabilities, Current 2.11M USD -29.6%
Liabilities, Current 8.66M USD -2.61%
Operating Lease, Liability, Noncurrent 27.6M USD -14.2%
Liabilities 36.3M USD -11.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 731K USD
Retained Earnings (Accumulated Deficit) -255M USD -37.9%
Stockholders' Equity Attributable to Parent 223M USD -19.4%
Liabilities and Equity 260M USD -18.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 126M shares +0.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.41M USD -92.8%
Operating Lease, Liability 31.6M USD -11.4%
Depreciation 2.08M USD +28.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -67.4M USD -12%
Lessee, Operating Lease, Liability, to be Paid 41.2M USD -14.6%
Property, Plant and Equipment, Gross 10.4M USD +23.3%
Operating Lease, Liability, Current 3.96M USD +14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.87M USD -4.34%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.18M USD +2.72%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.59M USD -23.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.89M USD +0.16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.82M USD -15.6%
Additional Paid in Capital 478M USD +2.93%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%